Status:

RECRUITING

Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents

Lead Sponsor:

Children's Cancer Group, China

Collaborating Sponsors:

Shanghai Children's Medical Center

Nanjing Children's Hospital

Conditions:

Mature B-cell Non-Hodgkin Lymphoma

Eligibility:

All Genders

Up to 18 years

Phase:

PHASE2

PHASE3

Brief Summary

The purpose of this study is to test whether intensive chemotherapy combined with early, adequate, and intensive use of Rituximab for aggressive B-NHL in children and adolescents can improve the EFS a...

Detailed Description

In our previous study (CCCG-BNHL-2015), four-year EFS was 88.3%, mostly owing to the use of Rituximab. However, four-year EFS was only 73% for group R4. And three-year EFS was even lower, 61% for stag...

Eligibility Criteria

Inclusion

  • Histology or cytologically confirmed matureB-cell NHL/AL(Burkitt, DLBCL, PMLBL,or aggressive mature B-cell NHL non other specified or specifiable) Able to comply with scheduled follow-up and with management of toxicity Signed informed consent

Exclusion

  • Follicular lymphoma, MALT and nodular marginal zone are not included into this therapeutic study Patients with congenital immunodeficiency, chromosomal breakage syndrome, prior organ transplantation, previous malignancy of any type, or known positive HIV serology.
  • Evidence of pregnancy or lactation period. Past or current anti-cancer treatment except corticosteroids during less than one week.
  • Exclusion criteria related to rituximab:
  • Tumor cell negative for CD20. Prior exposure to rituximab. Hepatitis B carrier status history of HBV or positive serology.

Key Trial Info

Start Date :

July 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2030

Estimated Enrollment :

87 Patients enrolled

Trial Details

Trial ID

NCT07168980

Start Date

July 1 2025

End Date

June 30 2030

Last Update

September 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shanghai Children's Medical Center

Shanghai, Shanghai Municipality, China, 201315